• Discuss the treatment landscape for genitourinary malignancies
• Examine the evolving role of genomics in the treatment of renal cell carcinoma, bladder cancer, and prostate cancer
• Analyze therapies in late-stage development and how they will be utilized as treatment options
• Engage with leading experts to deliberate newest practices and novel therapies